Stay updated on Atezolizumab and Epacadostat Combination Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab and Epacadostat Combination Clinical Trial page.

Latest updates to the Atezolizumab and Epacadostat Combination Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.5.3 appears on the page, replacing the prior v3.5.2. This seems to reflect a minor platform update rather than a modification to the study data or eligibility criteria.SummaryDifference0.1%

- Check14 days agoChange DetectedThe page’s study record content and identifiers are updated, including a new last update posted date and refreshed formatting/values for study listing details. Older text about the study timeline and dose-description entries is replaced by the newer revision (e.g., showing updated last update timestamps and a more complete list of epacadostat dosing cohorts).SummaryDifference6%

- Check21 days agoNo Change Detected
- Check42 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page shows revision v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check78 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedA new Revision: v3.4.1 is shown, and the notice about government funding lapse was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Atezolizumab and Epacadostat Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab and Epacadostat Combination Clinical Trial page.